Jiangxi Fushine Pharmaceutical Co., Ltd.
Shenzhen Stock Exchange 300497.SZ
Jiangxi Fushine Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) on January 27, 2025: 1.76
Jiangxi Fushine Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) is 1.76 on January 27, 2025, a 10.62% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
-
Jiangxi Fushine Pharmaceutical Co., Ltd. 52-week high Price to Book Ratio (P/B) is 2.87 on November 08, 2024, which is 62.94% above the current Price to Book Ratio (P/B).
-
Jiangxi Fushine Pharmaceutical Co., Ltd. 52-week low Price to Book Ratio (P/B) is 1.19 on February 05, 2024, which is -32.14% below the current Price to Book Ratio (P/B).
-
Jiangxi Fushine Pharmaceutical Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 1.91.
Key data
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Don’t Miss A Beat
Shenzhen Stock Exchange: 300497.SZ
| CEO | Mr. Jian Hua Bao |
| IPO Date | Dec. 22, 2015 |
| Location | China |
| Headquarters | No. 2, Yuli Industrial Zone |
| Employees | 1,963 |
| Sector | Health Care |
| Industries | |
Description
Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products. It also provides contract research, development, and manufacturing services. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.
Key trends
Past 5 years
StockViz Staff
January 30, 2025
Any question? Send us an email